Rare Diseases and Orphan Drugs Global Forum 2018 - November 2018 - Hyatt Regency Belgrade
Speakers
Clevio Nobrega
Assistant Professor
University of Algarve
Ricardo Hermosilla
Translational Medicine Leader
F. Hoffmann-La Roche Ltd
Dr. med. univ. Jama Nateqi
CEO
Symptoma
Cesare Spadoni
Chairman
aPODD Fundation
Gulce Belgin
General Manager
Luna Pharma Consulting Ltd
Malcolm Allison
Director and Owner
InterComm International Ltd
Christian Girard
Corporate Advisor
Advisory & Intelligence
Prof. Matthias Schonermark
Managing Partner
SKC Beratungsgesellschaft
Rebecca Stewart
Co-Founder
Rare Revolution magazine
David Edward Rose
Patient
ALASTAIR KENT OBE
Director
Genetic Alliance UK
Guido J.R. Zaman, Ph.D.
Head of Biology
NTRC
Sonja Pavlovic, Ph.D.
Principal Investigator
University of Belgrade
THOMAS THEELEN
Business Development Officer
Univercells
Dr Vladimir Cmiljanovic
CEO
Swiss Rockets